Another Vioxx Editorial from The New England Journal of Medicine

The New England Journal of Medicine has published a second editorial regarding the VIGOR study.

The Journal claims that Merck withheld information that could have changed the results of the study.

Here is some supplementary information referenced in the second editorial.

Here is some related correspondence to the original NEJM editorial.